Dr Richard V Dowden, MD in Mayfield Heights, OH - Plastic Surgery

Dr Richard V Dowden, MD is a Plastic Surgery physician based in Mayfield Heights, Ohio. Dr Richard V Dowden is licensed to practice in Ohio (license number 43187) and his current practice location is 6770 Mayfield Rd, Suite 410, Mayfield Heights, Ohio. He can be reached at his office (for appointments etc.) via phone at (440) 449-7470.

NPI number for Dr Richard V Dowden is 1528141249 and his current mailing address is 6770 Mayfield Rd, Suite 410, Mayfield Heights, Ohio. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1528141249.

Contact Information

	Dr Richard V Dowden, MD
	6770 Mayfield Rd, Suite 410, Mayfield Heights, OH 44124
	(440) 449-7470
	Not Available

Physician's Profile

Full Name	Dr Richard V Dowden
Gender	Male
Speciality	Plastic Surgery
Location	6770 Mayfield Rd, Mayfield Heights, Ohio
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1528141249
Provider Enumeration Date: 10/24/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Richard V Dowden such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1528141249	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208200000X	Plastic Surgery	43187 (Ohio)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Richard V Dowden is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Richard V Dowden, MD 6770 Mayfield Rd, Suite 410, Mayfield Heights, OH 44124 Ph: (440) 449-7470	Dr Richard V Dowden, MD 6770 Mayfield Rd, Suite 410, Mayfield Heights, OH 44124 Ph: (440) 449-7470

News Archive

Few health insurance options for people with pre-existing conditions

The Los Angeles Times: "For people with preexisting medical conditions, looking for health insurance in the private market may feel like the ultimate fool's errand. … When the health reform law takes full effect in 2014, insurers will no longer be able to deny coverage to people with preexisting medical conditions. In the meantime, new federally funded high-risk pools for the medically uninsurable have been established. To qualify, you have to be without insurance for six months.

AGA guidelines recommend anti-TNF-α biologic agents to induce remission in Crohn's disease patients

The anti-TNF-α biologic agents, such as infliximab or adalimumab, are recommended to induce remission in patients with moderately severe Crohn's disease , according to a new guideline from the American Gastroenterological Association. Additionally, the guidelines recommend against using thiopurines or methotrexate alone to induce remission in these patients. The new guideline and accompanying technical review have been published in Gastroenterology, the official journal of the AGA Institute.

FDA-regulated study investigates use of child's stem cells for acquired sensorineural hearing loss

Cord Blood Registry, the world's largest and most experienced newborn stem cell company, announces the start of a U.S. Food and Drug-regulated study being conducted at Florida Hospital for Children in Orlando to investigate the use of a child's stem cells from their own stored umbilical cord blood as a treatment for acquired sensorineural hearing loss.

Medical interpreters to bring equitable healthcare to LEP patients closer

Patients in the United States with limited English proficiency (LEP) continue to face language barriers that threaten their health and undermine their well-being. But today they are one step closer to quality, equitable healthcare with the launch of the first National Certification for Medical Interpreters.

Engineered cells take control of the cells and microenvironment following transplantation

In work that could jumpstart the promising field of cell therapy, in which cells are transplanted into the body to treat a variety of diseases and tissue defects, researchers at Brigham and Women's Hospital (BWH) have engineered cells that could solve one of the key challenges associated with the procedure: control of the cells and their microenvironment following transplantation.

Dr Richard V Dowden, MD - Plastic Surgery in Mayfield Heights, OH